|
During the 1960s and 1970s, Timothy Leary was arrested 36 times. As a clinical psychologist at Harvard University, he founded the Harvard Psilocybin Project which he led from 1960 to 1962, testing the therapeutic effects of lysergic acid diethylamide (LSD and psilocybin which, at the time, were legal in the United States. In 1968, both were declared a Schedule 1 controlled substance (no medical value) as Congress felt they were a “cultural threat to American values and the Vietnam war effort.” In 2019, Denver decriminalized psilocybin. In 2020, Oregon became the first state to both decriminalize psilocybin and legalize it for therapeutic use. Colorado followed in 2022. Ketamine was first approved for use in the United States in 1970. It became a Schedule III non-narcotic substance under the Controlled Substance Act in 1999. Medical marijuana is now fully legal in 37 states (but still illegal under federal law as a Schedule I drug).
Join us on April 6, to listen to Dr. Jim Fidelibus, a member of our JACO community, as well as Dylan Rivard, a counselor in Colorado who uses psychedelics in his practice, to explore how this evolution impacts us today.
What happens when psychedelics are used in treatment? What are the stages of a psychedelic journey? Would Jung believe psychedelics to be of value or would he continue to challenge the value of a spiritual experience with a pill? How do/can they impact the individuation process? Can they truly help to open the door to a numinous experience? What is some of the current research and leading theories of psychedelic therapy? What happens when one compares and contrasts emerging psychological models with traditionally held indigenous viewpoints? What role do the issues of culture and oppression play in the emerging psychedelic landscape?
CEUs will be available. The cost is $45 for members / $55 for non-members.
| 
